Standard Versus Extended Pelvic Lymphadenectomy in Patients With Bladder Cancer
Extended PLND can lead to favorable recurrence-free survival and 5-year recurrence rates. However, retrospective observational studies mainly drive the evidence, and additional RCTs are required to reach a definitive conclusion.
Authors
- Mushood Ahmed (ORCID: https://orcid.org/0000-0001-9872-8224)
- Zain Ul Abideen (ORCID: https://orcid.org/0000-0002-8941-3615)
- Asad Ramzan (ORCID: https://orcid.org/0000-0002-2682-6041)
- Muhammad Hamza (ORCID: https://orcid.org/0000-0003-1445-3986)
- Muhammad Saqib (ORCID: https://orcid.org/0000-0002-2796-1413)
- Hira Waris (ORCID: https://orcid.org/0009-0009-8714-4018)
- Abdul Haseeb (ORCID: https://orcid.org/0000-0002-7942-4062)
- Nouman Aziz (ORCID: https://orcid.org/0009-0006-2305-3721)
- Muhammad Ayyan (ORCID: https://orcid.org/0009-0002-6298-5987)
- Hira Habib (ORCID: https://orcid.org/0009-0006-4013-4945)
- Hunaina Aman
- Aftab Azad
- Aiza Bint-e-Shafqat
Institutions
- Liaquat University of Medical & Health Sciences (PK)
- Holy Family Hospital (IN)
- King Edward Medical University (PK)
- Rawalpindi Medical University (PK)
- Allama Iqbal Medical College (PK)
- Wyckoff Heights Medical Center (US)
- Huntsman Cancer Institute (US)
- Bahawal Victoria Hospital (PK)
- HITEC University (PK)
- Shifa International Hospital (PK)
Publication Details
- Journal
- American Journal of Clinical Oncology
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1097/coc.0000000000001206
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.01